{"product_id":"docmeded-2026-current-challenges-in-gynecologic-and-obstetric-pathology","title":"DocmedED 2026 Current Challenges in Gynecologic and Obstetric Pathology","description":"\u003cdiv class=\"form-group\"\u003e\r\n\u003cdiv class=\"form-control-plaintext\"\u003e\r\n\u003cdiv class=\"form-group\"\u003e\r\n\u003ch1 data-section-id=\"rmn4u3\" data-start=\"0\" data-end=\"73\"\u003eDocmedED 2026 Current Challenges in Gynecologic and Obstetric Pathology\u003c\/h1\u003e\r\n\u003cp data-start=\"75\" data-end=\"172\"\u003e\u003cstrong data-start=\"75\" data-end=\"172\"\u003ePractical Updates in Gynecologic Oncology, Placental Pathology \u0026amp; Female Genital Tract Disease\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp data-start=\"174\" data-end=\"533\"\u003eThe \u003cstrong data-start=\"178\" data-end=\"253\"\u003eDocmedED 2026 Current Challenges in Gynecologic and Obstetric Pathology\u003c\/strong\u003e course provides a comprehensive review of the latest developments in gynecologic and obstetric pathology, focusing on diagnostic challenges, updated disease classifications, molecular pathology, and clinically relevant pathologic findings that directly impact patient management.\u003c\/p\u003e\r\n\u003cp data-start=\"535\" data-end=\"890\"\u003eDesigned by leading experts in gynecologic pathology, this educational program highlights major updates from the \u003cstrong data-start=\"648\" data-end=\"728\"\u003e2025 World Health Organization (WHO) Classification of Female Genital Tumors\u003c\/strong\u003e, advances in molecular diagnostics, and practical approaches to evaluating placental disorders, gynecologic malignancies, and lower female genital tract lesions.\u003c\/p\u003e\r\n\r\n\u003ch2 data-section-id=\"1qyxylb\" data-start=\"892\" data-end=\"910\"\u003eCourse Features\u003c\/h2\u003e\r\n\u003cul data-start=\"912\" data-end=\"1173\"\u003e\r\n \t\u003cli data-section-id=\"1ghr4t1\" data-start=\"912\" data-end=\"931\"\u003e12 Video Lectures\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1trmda5\" data-start=\"932\" data-end=\"952\"\u003e1 PDF Presentation\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1lg4z8q\" data-start=\"953\" data-end=\"974\"\u003eTotal Size: 7.56 GB\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1me5f2\" data-start=\"975\" data-end=\"1003\"\u003eExpert Faculty Instruction\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"m5vtp6\" data-start=\"1004\" data-end=\"1038\"\u003eEvidence-Based Pathology Updates\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1stfm1d\" data-start=\"1039\" data-end=\"1071\"\u003eWHO 2025 Classification Review\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"q8svr0\" data-start=\"1072\" data-end=\"1106\"\u003eMolecular Pathology Applications\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"j48g54\" data-start=\"1107\" data-end=\"1137\"\u003eImmunohistochemistry Updates\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"gjoyac\" data-start=\"1138\" data-end=\"1173\"\u003eCase-Based Diagnostic Discussions\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-section-id=\"a88ac2\" data-start=\"1175\" data-end=\"1194\"\u003eProgram Overview\u003c\/h2\u003e\r\n\u003cp data-start=\"1196\" data-end=\"1509\"\u003eGynecologic and obstetric pathology continues to evolve rapidly with significant advances in tumor classification, molecular diagnostics, prognostic biomarkers, and targeted therapies. Accurate pathologic diagnosis plays a critical role in guiding clinical management, therapeutic decisions, and patient outcomes.\u003c\/p\u003e\r\n\u003cp data-start=\"1511\" data-end=\"1735\"\u003eThis course provides practical guidance for pathologists and clinicians who evaluate gynecologic and obstetric specimens, emphasizing diagnostic accuracy, classification updates, and clinically meaningful pathology findings.\u003c\/p\u003e\r\n\u003cp data-start=\"1737\" data-end=\"1940\"\u003eSpecial attention is given to placental pathology, endometrial and ovarian carcinomas, uterine mesenchymal tumors, cervical pathology, and molecular testing strategies that influence modern patient care.\u003c\/p\u003e\r\n\r\n\u003ch2 data-section-id=\"1scsphp\" data-start=\"1942\" data-end=\"1964\"\u003eLearning Objectives\u003c\/h2\u003e\r\n\u003cp data-start=\"1966\" data-end=\"2031\"\u003eUpon completion of this activity, participants should be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"2033\" data-end=\"2637\"\u003e\r\n \t\u003cli data-section-id=\"1tcezex\" data-start=\"2033\" data-end=\"2135\"\u003eRecognize clinically significant placental abnormalities associated with adverse pregnancy outcomes.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"hj2yx3\" data-start=\"2136\" data-end=\"2228\"\u003eApply updates introduced in the 2025 WHO classification of female genital tract neoplasms.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1to936a\" data-start=\"2229\" data-end=\"2318\"\u003eUtilize molecular and immunohistochemical testing appropriately in gynecologic cancers.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"pkvca8\" data-start=\"2319\" data-end=\"2392\"\u003eDifferentiate subtypes of high-grade endometrial and ovarian carcinoma.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"izavq7\" data-start=\"2393\" data-end=\"2456\"\u003eIdentify uterine mesenchymal tumors with malignant potential.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1r5vov\" data-start=\"2457\" data-end=\"2549\"\u003eEvaluate vulvar, vaginal, and cervical neoplasms using contemporary diagnostic approaches.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1ttpqps\" data-start=\"2550\" data-end=\"2637\"\u003eImprove diagnostic accuracy in challenging gynecologic and obstetric pathology cases.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-section-id=\"1ti0lfk\" data-start=\"2639\" data-end=\"2661\"\u003eCore Topics Covered\u003c\/h2\u003e\r\n\u003ch3 data-section-id=\"1ltdbud\" data-start=\"2663\" data-end=\"2686\"\u003ePlacental Pathology\u003c\/h3\u003e\r\n\u003cul data-start=\"2688\" data-end=\"2887\"\u003e\r\n \t\u003cli data-section-id=\"1lrtevb\" data-start=\"2688\" data-end=\"2709\"\u003ePlacental Disorders\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"18e9jly\" data-start=\"2710\" data-end=\"2742\"\u003eMaternal Vascular Malperfusion\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"153b7zk\" data-start=\"2743\" data-end=\"2772\"\u003eFetal Vascular Malperfusion\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"wsptx4\" data-start=\"2773\" data-end=\"2805\"\u003ePlacental Inflammatory Lesions\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1kwqmt4\" data-start=\"2806\" data-end=\"2843\"\u003eRecurrent Pregnancy Risk Assessment\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ll4x9h\" data-start=\"2844\" data-end=\"2887\"\u003eClinically Significant Placental Findings\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-section-id=\"1wzlumf\" data-start=\"2889\" data-end=\"2924\"\u003eWHO 2025 Classification Updates\u003c\/h3\u003e\r\n\u003cul data-start=\"2926\" data-end=\"3065\"\u003e\r\n \t\u003cli data-section-id=\"a3yiit\" data-start=\"2926\" data-end=\"2969\"\u003eFemale Genital Tract Tumor Classification\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"a8cr8h\" data-start=\"2970\" data-end=\"2997\"\u003eEmerging Disease Entities\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1u0iqp5\" data-start=\"2998\" data-end=\"3027\"\u003eUpdated Diagnostic Criteria\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"rubupd\" data-start=\"3028\" data-end=\"3065\"\u003eContemporary Classification Systems\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-section-id=\"11froto\" data-start=\"3067\" data-end=\"3102\"\u003eGynecologic Molecular Pathology\u003c\/h3\u003e\r\n\u003cul data-start=\"3104\" data-end=\"3255\"\u003e\r\n \t\u003cli data-section-id=\"1153e58\" data-start=\"3104\" data-end=\"3147\"\u003eMolecular Testing in Gynecologic Oncology\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1b9628q\" data-start=\"3148\" data-end=\"3171\"\u003ePredictive Biomarkers\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1v40ctb\" data-start=\"3172\" data-end=\"3192\"\u003ePrognostic Markers\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1xmc8xn\" data-start=\"3193\" data-end=\"3221\"\u003eTargeted Therapy Selection\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"17m4ljn\" data-start=\"3222\" data-end=\"3255\"\u003ePrecision Medicine Applications\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-section-id=\"1dbykij\" data-start=\"3257\" data-end=\"3306\"\u003eImmunohistochemistry in Gynecologic Pathology\u003c\/h3\u003e\r\n\u003cul data-start=\"3308\" data-end=\"3422\"\u003e\r\n \t\u003cli data-section-id=\"1gz348q\" data-start=\"3308\" data-end=\"3347\"\u003eDiagnostic Immunohistochemical Panels\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"13um8dr\" data-start=\"3348\" data-end=\"3370\"\u003eTumor Classification\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"lx0oui\" data-start=\"3371\" data-end=\"3395\"\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"k829l0\" data-start=\"3396\" data-end=\"3422\"\u003eBiomarker Interpretation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-section-id=\"b2fj5n\" data-start=\"3424\" data-end=\"3449\"\u003eEndometrial Carcinoma\u003c\/h3\u003e\r\n\u003cul data-start=\"3451\" data-end=\"3582\"\u003e\r\n \t\u003cli data-section-id=\"1kbz37\" data-start=\"3451\" data-end=\"3485\"\u003eHigh-Grade Endometrial Carcinoma\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1unjwbg\" data-start=\"3486\" data-end=\"3512\"\u003eMolecular Classification\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ar32kg\" data-start=\"3513\" data-end=\"3534\"\u003eHistologic Subtypes\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1nzhii8\" data-start=\"3535\" data-end=\"3555\"\u003ePrognostic Factors\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"11e9pc\" data-start=\"3556\" data-end=\"3582\"\u003eTherapeutic Implications\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-section-id=\"1mvkawu\" data-start=\"3584\" data-end=\"3605\"\u003eOvarian Neoplasms\u003c\/h3\u003e\r\n\u003cul data-start=\"3607\" data-end=\"3726\"\u003e\r\n \t\u003cli data-section-id=\"7ubko5\" data-start=\"3607\" data-end=\"3637\"\u003eHigh-Grade Ovarian Carcinoma\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1urhlxu\" data-start=\"3638\" data-end=\"3656\"\u003eSerous Carcinoma\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"lx0oui\" data-start=\"3657\" data-end=\"3681\"\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1a4ax59\" data-start=\"3682\" data-end=\"3702\"\u003eMolecular Features\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1dbl0oo\" data-start=\"3703\" data-end=\"3726\"\u003eClinical Significance\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-section-id=\"1ip9c1e\" data-start=\"3728\" data-end=\"3758\"\u003eUterine Mesenchymal Tumors\u003c\/h3\u003e\r\n\u003cul data-start=\"3760\" data-end=\"3887\"\u003e\r\n \t\u003cli data-section-id=\"ivlyms\" data-start=\"3760\" data-end=\"3780\"\u003eLeiomyoma Variants\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ugq3ih\" data-start=\"3781\" data-end=\"3803\"\u003eSmooth Muscle Tumors\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"glyp7w\" data-start=\"3804\" data-end=\"3835\"\u003eEndometrial Stromal Neoplasms\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"g2zlu7\" data-start=\"3836\" data-end=\"3854\"\u003eUterine Sarcomas\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"107etg5\" data-start=\"3855\" data-end=\"3887\"\u003eMalignant Potential Assessment\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-section-id=\"qm23ss\" data-start=\"3889\" data-end=\"3911\"\u003eCervical Pathology\u003c\/h3\u003e\r\n\u003cul data-start=\"3913\" data-end=\"4054\"\u003e\r\n \t\u003cli data-section-id=\"kkvqeu\" data-start=\"3913\" data-end=\"3947\"\u003eSquamous Intraepithelial Lesions\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"9dzvod\" data-start=\"3948\" data-end=\"3977\"\u003eCervical Squamous Neoplasia\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"5fiok7\" data-start=\"3978\" data-end=\"4002\"\u003eHPV-Associated Disease\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"cbd99y\" data-start=\"4003\" data-end=\"4024\"\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"16tb8w7\" data-start=\"4025\" data-end=\"4054\"\u003eContemporary Classification\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-section-id=\"19l1ezs\" data-start=\"4056\" data-end=\"4090\"\u003eEndocervical Glandular Lesions\u003c\/h3\u003e\r\n\u003cul data-start=\"4092\" data-end=\"4192\"\u003e\r\n \t\u003cli data-section-id=\"15u2k0y\" data-start=\"4092\" data-end=\"4116\"\u003eAdenocarcinoma In Situ\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1rqgge3\" data-start=\"4117\" data-end=\"4146\"\u003eEndocervical Adenocarcinoma\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"miiz8q\" data-start=\"4147\" data-end=\"4168\"\u003eGlandular Dysplasia\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ylkdv\" data-start=\"4169\" data-end=\"4192\"\u003eDiagnostic Algorithms\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3 data-section-id=\"ffo4a7\" data-start=\"4194\" data-end=\"4224\"\u003eVulvar \u0026amp; Vaginal Pathology\u003c\/h3\u003e\r\n\u003cul data-start=\"4226\" data-end=\"4353\"\u003e\r\n \t\u003cli data-section-id=\"f5v4j6\" data-start=\"4226\" data-end=\"4253\"\u003eVulvar Squamous Neoplasia\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"fsojwm\" data-start=\"4254\" data-end=\"4273\"\u003eVaginal Neoplasms\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1150gx5\" data-start=\"4274\" data-end=\"4295\"\u003eMelanocytic Lesions\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1yb8xm0\" data-start=\"4296\" data-end=\"4316\"\u003eMesenchymal Tumors\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1s7jps0\" data-start=\"4317\" data-end=\"4353\"\u003eRare Lower Genital Tract Disorders\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-section-id=\"1m9xcqo\" data-start=\"4355\" data-end=\"4373\"\u003eTarget Audience\u003c\/h2\u003e\r\n\u003cp data-start=\"4375\" data-end=\"4400\"\u003eThis course is ideal for:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"4402\" data-end=\"4662\"\u003e\r\n \t\u003cli data-section-id=\"biiv77\" data-start=\"4402\" data-end=\"4416\"\u003ePathologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1mq3jgk\" data-start=\"4417\" data-end=\"4443\"\u003eGynecologic Pathologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"mrpk3r\" data-start=\"4444\" data-end=\"4467\"\u003eSurgical Pathologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"3nl10y\" data-start=\"4468\" data-end=\"4489\"\u003ePathology Residents\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"10yt9zz\" data-start=\"4490\" data-end=\"4509\"\u003ePathology Fellows\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"kivt4l\" data-start=\"4510\" data-end=\"4543\"\u003eObstetricians and Gynecologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"18s622z\" data-start=\"4544\" data-end=\"4569\"\u003eGynecologic Oncologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1lnlai3\" data-start=\"4570\" data-end=\"4607\"\u003eMaternal-Fetal Medicine Specialists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1bg468m\" data-start=\"4608\" data-end=\"4631\"\u003eAcademic Pathologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ibbxdo\" data-start=\"4632\" data-end=\"4662\"\u003eCommunity-Based Pathologists\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-section-id=\"1roq8pt\" data-start=\"4664\" data-end=\"4689\"\u003eEducational Highlights\u003c\/h2\u003e\r\n\u003cp data-start=\"4691\" data-end=\"4724\"\u003e✔ WHO 2025 Classification Updates\u003c\/p\u003e\r\n\u003cp data-start=\"4726\" data-end=\"4763\"\u003e✔ Gynecologic Cancer Pathology Review\u003c\/p\u003e\r\n\u003cp data-start=\"4765\" data-end=\"4794\"\u003e✔ Placental Pathology Updates\u003c\/p\u003e\r\n\u003cp data-start=\"4796\" data-end=\"4843\"\u003e✔ Molecular Diagnostics in Gynecologic Oncology\u003c\/p\u003e\r\n\u003cp data-start=\"4845\" data-end=\"4880\"\u003e✔ Immunohistochemistry Applications\u003c\/p\u003e\r\n\u003cp data-start=\"4882\" data-end=\"4930\"\u003e✔ Endometrial \u0026amp; Ovarian Carcinoma Classification\u003c\/p\u003e\r\n\u003cp data-start=\"4932\" data-end=\"4970\"\u003e✔ Uterine Mesenchymal Tumor Evaluation\u003c\/p\u003e\r\n\u003cp data-start=\"4972\" data-end=\"5008\"\u003e✔ Cervical and HPV-Related Pathology\u003c\/p\u003e\r\n\u003cp data-start=\"5010\" data-end=\"5042\"\u003e✔ Case-Based Diagnostic Teaching\u003c\/p\u003e\r\n\u003cp data-start=\"5044\" data-end=\"5074\"\u003e✔ Practical Clinical Relevance\u003c\/p\u003e\r\n\r\n\u003ch2 data-section-id=\"1ilfxpc\" data-start=\"5076\" data-end=\"5107\"\u003eClinical \u0026amp; Educational Value\u003c\/h2\u003e\r\n\u003cp data-start=\"5109\" data-end=\"5504\"\u003eThe DocmedED 2026 Current Challenges in Gynecologic and Obstetric Pathology course delivers a practical and up-to-date review of modern gynecologic pathology. Through detailed discussions of classification systems, molecular pathology, placental disease, and gynecologic neoplasia, participants gain valuable knowledge that improves diagnostic confidence and supports optimal patient management.\u003c\/p\u003e\r\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e01 Placental Pathology A Sailing Guide\u003c\/li\u003e\r\n \t\u003cli\u003e02 How Molecular Classification Informs Endometrial Cancer Diagnosis and Management\u003c\/li\u003e\r\n \t\u003cli\u003e03 High Grade Endometrial Carcinoma Difficult but Relevant\u003c\/li\u003e\r\n \t\u003cli\u003e04 Mastering Your Fleet of Biomarker Tests in Gynecologic Cancer\u003c\/li\u003e\r\n \t\u003cli\u003e05 Ovarian Epithelial Neoplasia Made Easy\u003c\/li\u003e\r\n \t\u003cli\u003e06 Warming Up to Frozen Section Diagnosis of Ovarian Masses\u003c\/li\u003e\r\n \t\u003cli\u003e07 Smooth Sailing to Uterine Mesenchymal Neoplasia Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003e08 Non-Smooth Sailing to Uterine Mesenchymal Neoplasia Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003e09 Your Compass to Lower Genital Tract Pathology Navigation Squamous Lesions\u003c\/li\u003e\r\n \t\u003cli\u003e10 Your Compass to Lower Genital Tract Pathology Navigation Warts, Plaques and Rashes\u003c\/li\u003e\r\n \t\u003cli\u003e11 Your Compass to Lower Genital Tract Pathology Navigation Endocervical Lesions\u003c\/li\u003e\r\n \t\u003cli\u003e12 Your Compass to Lower Genital Tract Pathology Navigation Non-epithelial Lesions\u003c\/li\u003e\r\n \t\u003cli\u003ePATHGC26_ESyllabus\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Medical Amboss","offers":[{"title":"Default Title","offer_id":43020453216354,"sku":"MED-AMB09335","price":55.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/DocmedED-2026-Current-Challenges-in-Gynecologic-and-Obstetric-Pathology.webp?v=1781441399","url":"https:\/\/meducourse.com\/products\/docmeded-2026-current-challenges-in-gynecologic-and-obstetric-pathology","provider":"Meducourse","version":"1.0","type":"link"}